SEARCH

SEARCH BY CITATION

References

  • 1
    Grijsen ML, Steingrover R, Wit FWNM et al. No treatment versus 24 or 60 Weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS Med 2012; 9: e1001196.
  • 2
    Fidler S, Investigators ST. The effect of short-course antiretroviral therapy in primary HIV infection: final results from an international randomised controlled trial; SPARTAC. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy, July 2011 [Abstract WELBX06].
  • 3
    Hogan CM, Degruttola V, Sun X et al. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis 2012; 205: 8796.
  • 4
    Fidler S, Fox J, Porter K, Weber J. Primary HIV infection: to treat or not to treat? Curr Opin Infect Dis 2008; 21: 410.
  • 5
    Nieuwkerk PT, Reijers MH, Weigel HM, Lange JM, Sprangers MA. Quality of life in maintenance vs prolonged induction therapy for HIV. JAMA 2000; 284: 178179.
  • 6
    Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis 2010; 202 (Suppl. 2): S278S288.
  • 7
    Bucciardini R, Fragola V, Massella M et al. Health-related quality of life outcomes in HIV-infected patients starting different combination regimens in a randomized multinational trial: the INITIO-QoL substudy. AIDS Res Hum Retroviruses 2007; 23: 12151222.
  • 8
    Carrieri P, Spire B, Duran S et al. Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 32: 3847.
  • 9
    Nieuwkerk PT, Gisolf EH, Colebunders R, Wu AW, Danner SA, Sprangers MA. Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS 2000; 14: 181187.
  • 10
    Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001; 15: 19851991.
  • 11
    Steingrover R, Pogany K, Fernandez Garcia E et al. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. AIDS 2008; 22: 15831588.
  • 12
    Wu AW, Rubin HR, Mathews WC et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786798.
  • 13
    Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36: 126137.
  • 14
    Johnson MO, Stallworth T, Neilands TB. The drugs or the disease? Causal attributions of symptoms held by HIV- positive adults on HAART. AIDS Behav 2003; 7: 109117.